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The exported proteins of Mycobacterium tuberculosis that are localized at the bacterial cell surface or secreted
into the environment are ideally situated to interact with host factors and to function in virulence. In this study,
we constructed a novel -lactamase reporter transposon and used it directly in M. tuberculosis for genome-wide
identification of exported proteins. From 177 -lactam-resistant transposon mutants, we identified 111 dif-
ferent exported proteins. The majority of these proteins have no known function, and for nearly half of the
proteins, our demonstration that they are exported when fused to a -lactamase reporter is the first experi-
mental proof of their extracytoplasmic localization. The transposon mutants in our banked library were of
further value as a collection of mutants lacking individual exported proteins. By individually testing each of 111
mutants for growth in macrophages, six attenuated mutants with insertions in mce1A, mce1B, mce2F, rv0199,
ctaC, and lppX were identified. Given that much of the M. tuberculosis genome encodes proteins of unknown
function, our library of mapped transposon mutants is a valuable resource for efforts in functional genomics.
This work also demonstrates the power of a -lactamase reporter transposon that could be applied similarly
to other bacterial pathogens.
Mycobacterium tuberculosis is the causative agent of tuber-
culosis, a devastating disease that kills nearly 2 million people
each year (57). Following inhalation, M. tuberculosis survives
and replicates within phagosomal compartments of macro-
phages. The phagosome acidification and fusion with lyso-
somes that normally occur following phagocytosis are blocked
by M. tuberculosis (44, 56). Bacterial exported proteins, defined
here as both surface-exposed and secreted proteins, are ideally
positioned to interact with the host and promote this M. tuber-
culosis growth in macrophages.
M. tuberculosis has the conserved Sec and twin-arginine
translocation (Tat) pathways for exporting proteins with N-
terminal signal sequences beyond the cytoplasmic membrane.
M. tuberculosis also possesses specialized secretion systems,
namely, the SecA2 and ESX systems (35). These specialized
systems are not well understood, but at least some of the
proteins exported by these pathways lack identifiable export
signals. Despite long-standing interest in the exported proteins
of M. tuberculosis, many exported proteins have yet to be iden-
tified experimentally as such, and few have a demonstrated
function.
Mutagenesis with a reporter transposon is a classic approach
to first identify exported proteins and then use the resulting
transposon mutants to test the importance of these proteins in
virulence. TnphoA (30) is a reporter transposon used exten-
sively for this purpose. The toxin-coregulated pilus of Vibrio
cholerae (54) and several other virulence factors (5, 16, 39)
were discovered by screening TnphoA mutants. However,
TnphoA cannot be used directly in M. tuberculosis because of
endogenous enzymes that cleave the PhoA substrate (28).
In this study, we used the TEM-1 -lactamase (BlaTEM-1)
as an alternate reporter to identify exported proteins of M.
tuberculosis. The BlaTEM-1 reporter exploits the fact that
-lactamases must be exported beyond the cytoplasm in order
to cleave -lactam antibiotics before they target the cell wall
(53). A truncated BlaTEM-1 enzyme that lacks the endoge-
nous signal for export remains cytoplasmic and fails to protect
against -lactams. If a Sec or Tat signal sequence is fused to
BlaTEM-1, the reporter is exported and protects against
-lactams (34). Because M. tuberculosis is naturally resistant to
-lactams, a -lactam-sensitive blaC mutant of M. tuberculosis
is used with this reporter (17). A significant advantage of a
-lactamase reporter system is that it employs selection for
exported fusions, as opposed to the more labor-intensive
screen required with PhoA reporters.
By incorporating the BlaTEM-1 reporter coding sequence
into a mariner-based Himar1 transposon (43), we created
TnblaTEM-1, the first reporter transposon that can be used
directly in M. tuberculosis for genome-wide identification of
exported proteins. This reporter transposon allowed us to se-
lect in-frame insertions of the transposon in genes encoding
exported proteins by simply plating transposition reaction mix-
tures onto -lactam-containing agar. Among 177 -lactam-
resistant mutants, 111 different exported M. tuberculosis pro-
teins were identified. For nearly half of these proteins,
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the demonstration that they promoted export of a fused
BlaTEM-1 protein was the first experimental proof of their
subcellular location or topology. At the same time the reporter
transposon identified an exported protein, it provided an in-
sertion mutant in the respective open reading frame (ORF).
Therefore, our library of transposon mutants also represents
a valuable resource for assigning function to unknown ex-
ported proteins. In this study, we screened each of 111
unique TnblaTEM-1 insertion mutants for intracellular
growth phenotypes in bone marrow-derived macrophages.
Six mutants defective for growth in macrophages were ob-
tained. Thus, our library of mapped TnblaTEM-1 mutants
not only defined the subcellular location of 111 unique pro-
teins but also provided a useful mutant collection for eval-
uation in functional assays.
MATERIALS AND METHODS
Bacterial strains and culture. Cultivation of M. tuberculosis strains was per-
formed as described previously (8). Where needed, the growth medium was
supplemented with 50 g/ml hygromycin (Roche), 20 g/ml kanamycin (Acros
Chemicals), and 20 g/ml carbenicillin (Sigma). Tween was not included in
carbenicillin-containing Middlebrook 7H10 agar. E. coli strains were grown in
Luria-Bertani medium (LB; Fisher) with 150 g/ml hygromycin, 40 g/ml kana-
mycin, and 100 g/ml carbenicillin. M. tuberculosis strains used in this study were
derivatives of PM638 (17). Strains and plasmids used in this study, including the
attenuated mutants identified, are listed in Table 1. The complete list of trans-
poson mutants collected is provided in Table S1 in the supplemental material.
Construction of TnblaTEM-1 and complementation vectors. All PCRs were
done with an Expand Hi-Fidelity PCR kit (Roche) and 2 to 5% dimethyl sul-
foxide (DMSO). The transposon TnblaTEM-1 was constructed as follows. The
blaTEM-1 gene was PCR amplified without its signal sequence (blaTEM-1) from
pJES102 (34), using primers XbaTem-1F (5-ATCTAGACCAGAAACGCCTG
GTGAA-3) and SpeITemRev (5-GACTAGTGCTGGATCCGCAATTGTCT
TGG-3). The resulting product was cloned into pCR2.1 (Invitrogen), creat-
ing pJES122. To insert blaTEM-1 into the Himar1 transposon, we used
plasmid pSH1 (27). pSH1 carries a modified Himar1 transposon that contains
within its inverted repeats an oriR6K origin of replication and a hygromycin
resistance gene (Fig. 1). Outside the transposon, pSH1 contains the mariner
transposase gene (Tnpmar). pSH1 additionally contains a PacI site and a cos
sequence to facilitate cloning of the transposon into mycobacteriophages.
pSH1 was digested with XbaI, resulting in a 2.1-kb band and a 3.1-kb band.
The 2.1-kb band was ligated to a SpeI and XbaI blaTEM-1 fragment of
pJES122. The resulting plasmid was pJES123. This ligation abolished the
XbaI site at the 3 end of the blaTEM-1 fragment. pJES123 was then digested
with XbaI and ligated to the 3.1-kb XbaI fragment of pSH1, containing
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Genotype or description Source or reference
Strains
Escherichia coli
DH5 K-12 DH5 F 80dlacZM15 (lacZYA-argF)U169 deoR recA1 endA1 hsdR17 glnV44
thi-1 gyrA96 relA1
Gibco-BRL
DH5 pir K-12 DH5 F 80dlacZM15  (lacZYA-argF)U169 deoR recA1 endA1 hsdR17 glnV44
thi-1 gyrA96 relA pir
W. R. Jacobs, Jr.
Mycobacterium
mc2155 M. smegmatis ept-1 48
H37Rv Virulent M. tuberculosis 3
PM638 H37Rv blaC 17
MBTB126 PM638 carrying integrating vector pJES137 This study
MBTB204 PM638 with a TnblaTEM-1 insertion in mce1A (Rv0169) at amino acid 449 of 455 This study
MBTB190 PM638 with a TnblaTEM-1 insertion in mce1B (Rv0170) at amino acid 223 of 337 This study
MBTB183 PM638 with a TnblaTEM-1 insertion in rv0199 at amino acid 74 of 220 This study
MBTB156 PM638 with a TnblaTEM-1 insertion in mce2F (Rv0594) at amino acid 476 of 517 This study
MBTB381 PM638 with a TnblaTEM-1 insertion in ctaC (Rv2200c) at amino acid 351 of 364 This study
MBTB301 PM638 with a TnblaTEM-1 insertion in lppX (Rv2945c) at amino acid 82 of 234 This study
Plasmids
pCR2.1 bla aph ColE1; TA cloning vector Invitrogen
pMV261.kan aph Phsp60 oriM ColE1; multicopy mycobacterial shuttle plasmid 51
pJES102 aph Phsp60-blaTEM-1 (E. coli) oriM ColE1; blaTEM-1 from pCR2.1 cloned into pMV261.kan 34
pSH1 TnHimar1 oriR6Kg Hygr; shuttle vector carrying the Himar1 transposon 27
pJES123 hygR oriR6K blaTEM-1; intermediate cloning vector This study
pJES124 hygR oriR6K ColE1 aph TnblaTEM-1 Tnpmar cos; shuttle vector carrying TnblaTEM-1 This study
pJES137 hyg int attP ColE1 Phsp60 blaTEM-1; integrating hygromycin-marked vector with
constitutively expressed BlaTEM-1
This study
pJES153 aph Phsp60-mce2F oriE oriM; multicopy kanamycin-marked vector with constitutively
expressed mce2F
This study
pJES178 aph Phsp60-rv0199 oriE oriM; multicopy kanamycin-marked vector with constitutively
expressed Rv0199
This study
FIG. 1. Map of TnblaTEM-1. Plasmid pJES124 contains the signal
sequence-less blaTEM-1 gene cloned downstream of the left inverted
repeat (LIR) of a Himar1-based mariner transposon derived from
pSH1. The codon sequence of the inverted repeat is shown in the same
reading frame as the starting codons of BlaTEM-1. Tnpmar, mariner
transposase; hygR, hygromycin resistance gene.
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Tnpmar. In this manner, blaTEM-1 was cloned directly downstream of the left
inverted repeat of the transposon in the final vector, pJES124 (Fig. 1).
Construction of TnblaTEM-1 delivery phage. Plasmid pJES124 was cloned into
a nonessential region of the conditionally replicating mycobacteriophage
phAE159 as described previously (8), with minor modifications. phAE159 DNA
was digested with PacI and ligated to PacI-linearized pJES124. The ligated
phasmid was then packaged into  phage heads via the cos sites present on
pJES124, using a Max Plax kit (Epicentre). The  packaging step allowed recov-
ery of the newly ligated phasmid following transduction into E. coli. Phasmid
DNA phAE159::TnblaTEM-1 was isolated from hygromycin-resistant E. coli and
electroporated into Mycobacterium smegmatis mc2155. Electroporated cells were
mixed with late-log-phase M. smegmatis in top agar, poured onto solid agar, and
incubated at the permissive temperature of 30°C. A single plaque was isolated,
tested for temperature sensitivity, and expanded by permissive growth in M.
smegmatis. A high-titer lysate of phAE159::TnblaTEM-1 (	1010 PFU per ml) was
prepared.
Transposon mutagenesis in M. tuberculosis. Transposon mutagenesis of M.
tuberculosis strain PM638 was done via phage infection as described previously
(8). A small aliquot of each transposition reaction mix was plated on 7H10 agar
containing 50 g/ml hygromycin to estimate the total number of transposition
events for each reaction. The remainder of each transposition reaction mix was
plated on 7H10 agar containing 50 g/ml hygromycin and 20 g/ml carbenicillin.
Individual carbenicillin-resistant colonies were either patched or replated onto
7H10-hygromycin, with or without carbenicillin, to confirm -lactam resistance.
We calculated the number of transposon mutants needed to evaluate every gene
in the genome by using the following equation: N 
 [ln(1  P)/ln(1  f)]  6 reading
frames, where N 
 the number of transposon insertion mutants required to achieve
a probability of P that every 1-kb ORF is represented and f 
 the fraction of the
genome represented by each 1-kb gene (45). We determined the likelihood that
additional ORFs could still be identified by using the following Poisson-derived
equation: f[0] 
 em, where f[0] represents the still-mutable genes that may poten-
tially be recovered and m is the mean number of hits already recovered per gene
(18).
Identification of transposon insertion sites. Genomic DNAs were isolated
from transposon mutants by use of a guanidinium protocol as described previ-
ously (38). Genomic DNA was digested with BssHII and self-ligated, producing
a plasmid containing the transposon and flanking M. tuberculosis genomic DNA.
These plasmids were recovered by transformation into E. coli DH5 pir and
selection on LB agar with hygromycin. Resulting plasmid DNAs were then
sequenced to map the insertion sites. The following bioinformatic algorithms
were used to predict export signals: TMHMM (49), TopPred (13), TMPRED
(19), SignalP (6), Psort (37), LipoP (22), and TatP (7).
Complementation of selected M. tuberculosis TnblaTEM-1 mutants. The gene
encoding Rv0199 was PCR amplified from M. tuberculosis H37Rv genomic DNA
by use of primers EcoRV199F (5-AGATATCCAATGCCTGACGGGGAGCA
GAGC-3) and Rv0199Rev (5-ACGTTCGAAACCCACCACAG-3). The am-
plified product was cloned into pCR2.1 (Invitrogen), digested with EcoRV and
HindIII, and then ligated into MscI-HindIII-digested pMV261.kan. The result-
ing plasmid, carrying Rv0199 on a multicopy expression vector, was named
pJES178 (Table 1). The gene encoding Mce2F was PCR amplified from
M. tuberculosis H37Rv genomic DNA by use of the following primers:
mce2FecoRVfor1 (5-CGATATCACATGCTGACTCGCGCTATCG-3) and
mce2FnheRev1 (5-CGCTAGCTCAGCCGGTTGGTGCCAGCATC-3). The
amplified product was cloned into pCR2.1 and digested with EcoRV and NheI.
The resulting mce2F-containing fragment was ligated into pMV261.kan that had
been digested with MscI and NheI, generating pJES153. pJES178 and pJES153
DNAs were electroporated into the M. tuberculosis Rv0199::TnblaTEM-1 and
mce2F::TnblaTEM-1 transposon mutant strains to generate complemented
strains (8).
Macrophage infections. Murine bone marrow-derived macrophage infections
were completed as described previously (25). Briefly, bone marrow-derived mac-
rophages were obtained from 6- to 24-week-old female C57BL/6 mice and
seeded into 8-well chamber slides at 2  105 cells/well 24 h prior to infection. The
indicated M. tuberculosis strains were inoculated from freezer stocks grown to
mid-exponential phase, washed once in phosphate-buffered saline (PBS)–0.05%
Tween 80, resuspended in Dulbecco’s modified Eagle’s medium (DMEM), and
added to macrophages at a multiplicity of infection (MOI) of 1. Following a 4-h
uptake period, infected cells were washed with warm DMEM three times. A
subset of wells were then lysed, diluted, and plated on 7H10 agar to determine
uptake. Remaining infected wells were lysed, diluted, and plated at 5 days
postinfection to determine intracellular bacterial growth.
RESULTS AND DISCUSSION
Mutagenesis with the TnblaTEM-1 reporter transposon. Our
objective was to develop a reporter transposon that could be
used for large-scale identification of exported proteins in M.
tuberculosis. We selected the -lactamase blaTEM-1 reporter
for this purpose, as we previously established it to work directly
in M. tuberculosis to report on proteins exported by either Sec
or Tat pathways (34). For the transposon, we chose the mari-
ner-based Himar1 transposon because of its low degree of site
specificity—requiring only a TA dinucleotide sequence for in-
sertion—and its prior successful use in M. tuberculosis (46). To
construct the reporter transposon, we inserted the truncated
blaTEM-1 reporter directly downstream of the naturally exist-
ing open reading frame running through the left inverted re-
peat of a modified Himar1 transposon carried on plasmid
pSH1 (27) (Fig. 1). Important features of this Himar1 trans-
poson are the presence of a hygromycin resistance gene and an
oriR6K origin of replication, which later enabled recovery of
the transposon insertion site on a plasmid. A recombinant
mycobacteriophage, phAE159::TnblaTEM-1, was then con-
structed and used to deliver the reporter transposon into the
-lactam-sensitive blaC mutant of M. tuberculosis PM638 (17).
The average transposition frequency per phage infection was
1.2  106 transposon mutant/input bacillus, which is similar
to the frequency reported for other phage-delivered Himar
transposons in M. tuberculosis (4). Transposition events that
yielded in-frame insertions of TnblaTEM-1 in an ORF for an
exported protein produced an exported -lactamase fusion
protein. We selected exported BlaTEM-1 fusions by directly
plating the transposition reaction mix on agar containing hy-
gromycin plus the -lactam antibiotic carbenicillin. The aver-
age frequency of recovering -lactam-resistant colonies per
phage infection was 1  108.
Collection of TnblaTEM-1 library in M. tuberculosis. From an
estimated 81,000 transposon mutants, we selected 177 mutants
and confirmed their carbenicillin resistance (Table 2; see Table
TABLE 2. Description of M. tuberculosis TnblaTEM-1
transposon library
Parameter Value
Total no. of transposon mutantsa...................................................81,000
No. of confirmed carbenicillin-resistant insertion mutants......... 177
No. of in-frame insertions in ORFs............................................... 172
No. of unique ORFs identified....................................................... 111
No. of ORFs with standard Sec signal sequence ......................... 24
No. of ORFs with lipoprotein-type Sec signal sequence ............ 15
No. of ORFs with Tat signal sequence ......................................... 3
No. of ORFs with transmembrane domainsb ............................... 69
No. of ORFs with homologues only in mycobacteria ................. 41
No. of ORFs with homologues only in pathogenic
mycobacteriac ................................................................................ 16
No. of ORFs with no known or predicted functiond................... 66
a Estimated by plating a fraction of each transposition reaction mix on agar
containing hygromycin only.
b Includes proteins with at least one predicted transmembrane domain. Pro-
teins with transmembrane domains plus a Sec, Tat, or lipoprotein-type signal
sequence are most likely integral membrane proteins, and they are counted in
this category.
c Pathogenic mycobacteria searched included M. leprae, M. bovis, M. marinum,
M. ulcerans, and M. avium.
d Functions of individual ORFs are provided in Table S1 in the supplemental
material.
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S1 in the supplemental material). Because TnblaTEM-1 carries
the oriR6K origin of replication and the hygromycin resistance
gene, the transposon insertion site of each mutant was rescued
as a plasmid recovered from genomic DNA by restriction en-
donuclease digestion, self-ligation, and transformation into E.
coli. The transposon insertion site on the recovered plasmids
was then identified by DNA sequencing. Of the 177 carbeni-
cillin-resistant mutants, only 5 had insertions that were out of
frame or not in an ORF, and these transposon mutants are not
discussed further. The remaining 172 mutants had TnblaTEM-1
inserted in frame in an ORF. Some ORFs were identified more
than once, resulting in a total of 111 different ORFs identified.
Each mutant was stocked to create a sequence-defined library
of M. tuberculosis transposon mutants. Domain prediction al-
gorithms revealed each of the 111 ORFs to possess some type
of predicted export signal: a cleavable standard Sec signal
sequence, a cleavable lipoprotein-type Sec signal sequence, a
cleavable Tat signal sequence, and/or a transmembrane (TM)
domain (Table 2; see Table S1) (see Materials and Methods
for the algorithms used). The fact that nearly every -lactam-
resistant mutant possessed an in-frame insertion in an ORF
with features consistent with export demonstrated the speci-
ficity and selection power of this reporter.
For 43% of the ORFs we identified with TnblaTEM-1, this
was the first experimental evidence that the corresponding
protein is exported by M. tuberculosis (see Table S1 in the
supplemental material). Of the exported ORFs identified, 37%
had homologues only in other mycobacteria and 14% had
homologues only in pathogenic Mycobacterium spp. (Table 2;
see Table S1). Emphasizing how little is known about M. tu-
berculosis exported proteins, 59% of the ORFs we identified
had no known or predicted function (see Table S1). The dem-
onstration of export, especially for these unknown proteins, is
significant. Establishing the location of a protein is an impor-
tant step in determining its biological function and molecular
interactions.
For integral membrane proteins, the site of an active
TnblaTEM-1 insertion provides additional information about
protein topology, since active insertions must be fused to do-
mains localized on the extracytoplasmic side of the membrane.
Prediction programs often disagree on the number and loca-
tion of TM domains. Thus, experimental evidence is critical to
establishing the topology of integral membrane proteins. For
the 69 membrane proteins identified in this study, the insertion
site mapped an extracytosolic domain. While the degree of
saturation in our transposon library was insufficient to map the
full topology of membrane proteins, there were some integral
membrane proteins with multiple independent TnblaTEM-1
insertions. One such protein was MmpL4, a protein with an
undefined role in M. tuberculosis pathogenesis (15, 26, 46). By
combining the sites of active TnblaTEM-1 insertions with ear-
lier data obtained using M. smegmatis to identify exported
protein domains of MmpL4 (9), a total of seven extracytoplas-
mic sites could be delineated in this protein (see Fig. S1 in the
supplemental material). These experimental data help to build
a relatively refined topology map for this virulence factor of
unknown function.
At the start, we calculated that evaluation of 80,000 trans-
poson insertion mutants would give a 95% probability that all
genes of an average size of 1 kb in the 4.4-Mb M. tuberculosis
genome would be represented by at least one transposon in-
sertion in the proper reading frame (see Materials and Meth-
ods). After selecting 177 -lactam-resistant transposon inser-
tions from 81,000 transposon mutants, a Poisson calculation on
the number of times we repeatedly identified the same ORF
predicted that new ORFs could still be identified among future
carbenicillin-resistant mutants. Thus, even more exported M.
tuberculosis proteins could be identified in the future. How-
ever, as with any experimental approach, there will always be
some exported proteins that we cannot identify with this
method. Proteins that are essential or not expressed during in
vitro growth at a level sufficient for a fusion protein to promote
growth on selective media will be missed. While our reporter
transposon identifies proteins with N-terminal signal se-
quences, it misses proteins with C-terminal export signals. This
is because the blaTEM-1 stop codon on the transposon trun-
cates the C-terminal domains of proteins. Finally, we will miss
exported proteins that are incompatible with the BlaTEM-1
reporter itself. In fact, the unconventional exported proteins
Esat-6 and SodA, which are exported by the M. tuberculosis
ESX-1 (1) and SecA2 (41) systems, respectively, appear to fall
into this category. We did not identify these proteins with the
reporter transposon, and when N-terminal or C-terminal fu-
sions between BlaTEM-1 and Esat-6 or SodA were tested
directly, they failed to produce -lactam resistance, despite the
fusions being produced at high levels (as determined by im-
munoblotting [data not shown]). A possible explanation for
this incompatibility is that BlaTEM-1 is not exported or en-
zymatically active when fused to these unconventional ex-
ported proteins.
Screening the TnblaTEM-1 library for mutants with growth
defects in macrophages. In addition to defining the subcellular
locations of proteins, our mutant collection is a valuable re-
source for efforts to assign functions to ORFs. To demonstrate
this utility, we took an unbiased approach and screened our
library of mutants, each with a transposon insertion in a gene
encoding an exported protein, for growth in macrophages. A
representative transposon mutant for each of the 111 exported
ORFs identified was tested in duplicate for growth in resting
murine bone marrow-derived macrophages. For ORFs that
received multiple hits, a representative transposon mutant with
the most 5 insertion site was tested. The growth of each
transposon mutant was compared to that of M. tuberculosis
MBTB126, which is the blaC M. tuberculosis parent engineered
to express the nonexported BlaTEM-1 reporter. Among 111
transposon mutants tested, 6 mutants had reproducible and
statistically significant intracellular growth defects. These mu-
tants had TnblaTEM-1 insertions in one of the following genes:
mce1A, mce1B, mce2F, rv0199, ctaC, and lppX (see Fig. 2 to 5).
All six of these attenuated mutants were tested for growth in
broth culture, and all grew at the same rate as the MBTB126
parent strain (data not shown). As discussed below, the mac-
rophage phenotypes of two of these mutants were comple-
mented, proving that the transposon insertions were the cause
of the phenotypes. For the remaining four mutants, comple-
mentation experiments are pending. Therefore, we cannot yet
say with certainty that the disrupted ORF was the cause of the
intracellular growth defect.
For some of these mutants, our analysis was the first sug-
gestion that the ORF promotes growth in macrophages. For
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other mutants, the ORF was predicted to have a role in intra-
cellular growth by transposon site hybridization (TraSH) with
a saturating pool of M. tuberculosis mutants (40) or a pool of
2,500 Mycobacterium bovis BCG transposon mutants (50). For
mutants that fell into the second category, our direct testing
provided necessary validation of genes predicted earlier as
being important in macrophages.
Mce1A, Mce1B, and Mce2F. Each of the four mce operons
(mce1 to -4) in the M. tuberculosis genome contains six genes
encoding Mce protein family members (MceA to MceF) and
two YrbE homologues (12). In our TnblaTEM-1 library, we
obtained 15 unique transposon insertions in 13 genes in mce
operons (Fig. 2A). For six of these ORFs, our identification
with the reporter transposon is the first demonstration that the
protein is exported (see Table S1 in the supplemental mate-
rial). The function of Mce family members is still unclear, but
data suggest that they function as transporters, which is con-
sistent with an extracytoplasmic localization (21, 36).
When tested in macrophages, our TnblaTEM-1 insertion mu-
tants in mce1A and mce1B were attenuated for intracellular
growth (Fig. 2B). In published studies, there is debate about
the phenotype of mce1 mutants. An allelic exchange mutant in
which expression of the entire mce1 operon was defective was
reported to grow better than wild-type M. tuberculosis in mac-
rophages (47). However, TraSH analysis of pools of M. tuber-
culosis mutants predicts that transposon mutants with inser-
tions in genes spanning mce1B to mce1F are defective in
macrophages (40). Similarly, hybridization analysis of pooled
M. bovis BCG transposon mutants predicts that the majority of
mce1 genes contribute to intracellular growth (50). Our results
agree with the latter predictions. However, unlike the predic-
tions obtained with pooled mutant screens, when we tested
TnblaTEM-1 insertions in genes downstream of mce1B, we did
not observe macrophage growth defects. We speculate that
mutations downstream in the mce1 operon have more subtle
defects that are not evident when tested individually but are
revealed when tested in competition in pools of mutants. An-
other possibility is that the site of these mce1 downstream
insertions failed to disrupt function; however, several inser-
tions in mce1 were positioned early in an ORF, making this an
unlikely explanation for all cases (Fig. 2A; see Table S1).
We have yet to complement the mce1A and mce1B transpo-
son mutant phenotypes to rule out the possibility of polar
effects on downstream genes in the mce1 operon (spanning
genes fadD5 to mas1D) (12) (Fig. 2A). While not giving direct
proof, the lack of macrophage phenotypes with transposon
insertions in downstream mce1 genes suggests that the impact
of polar effects in our experiments is minimal. Published at-
tempts to complement individually disrupted mce1 genes were
unsuccessful, suggesting that complementation of our mce1
mutants may be a challenge (47).
A TnblaTEM-1 insertion mutation in mce2F also led to a
growth defect in macrophages (Fig. 2C). A complementation
experiment in which a wild-type copy of mce2F was expressed
from the hsp60 promoter in the mce2F::TnblaTEM-1 mutant
restored intracellular growth, demonstrating that the mutant
phenotype was due to the lack of Mce2F. This is the first
demonstration of Mce2F being important in macrophage
growth. The mce2F gene was not predicted to be important in
macrophages among pooled M. bovis BCG strains (50) or by
FIG. 2. Evaluation of M. tuberculosis mce::TnblaTEM-1 mutants in macrophages. (A) Representation of mce1, mce2, and mce4 operons in M.
tuberculosis H37Rv. Black triangles indicate TnblaTEM-1 insertion mutants with macrophage growth defects. White triangles mark TnblaTEM-1
insertion mutants that were not attenuated. The mce1 operon has two possible start sites and spans from either fadD5 or yrbE1A to mas1D (12,
20). The mce2 and mce4 operons are transcribed in a single transcript comprised of the genes shown (11, 24). (B) Murine bone marrow-derived
macrophages were infected with M. tuberculosis MBTB126, the mce1A::TnblaTEM-1 mutant, or the mce1B::TnblaTEM-1 mutant. At 4 h (day 0) and
3 and 5 days postinfection, macrophages were lysed and plated to enumerate intracellular bacteria. Error bars indicate standard deviations (SD)
of the means. (C) MBTB126 carrying pMV261.kan, the mce2F::TnblaTEM-1 mutant carrying pMV261.kan, and the mce2F::TnblaTEM-1 mutant
carrying a multicopy complementing vector expressing mce2F from a constitutive promoter (pJES153) were used to infect macrophages as
described for panel B. *, P  0.05. Each graph shows representative data from one of at least three independent replicate experiments.
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TraSH analysis of M. tuberculosis (40). Furthermore, an mce2
mutant of H37Rv was recently reported to grow normally in
the RAW cell line, although the mutant was attenuated in mice
(31).
We also recovered TnblaTEM-1 insertions in five different
genes in the mce4 operon (Fig. 2A; see Table S1 in the sup-
plemental material), but none of the resulting mutants was
attenuated for growth in macrophages. While Mce4 compo-
nents are important for bacterial growth in the mouse model of
infection (21, 46), our results agree with the TraSH analysis
predicting that mce4 is not important for growth in macro-
phages (40).
Rv0199. Rv0199 is a protein with limited homology to some
Mce-associated proteins but with no predicted function. How-
ever, Rv0199 is conserved in all mycobacteria examined to date
(32). The TnblaTEM-1 insertion positioned the BlaTEM-1
reporter after a single predicted TM domain at the N terminus
in Rv0199 (Fig. 3). This indicates that the majority of Rv0199
is located on the extracytoplasmic side of the membrane. The
rv0199::TnblaTEM-1 mutant was defective for growth in mac-
rophages, and this intracellular growth defect was comple-
mented by addition of a plasmid expressing rv0199 from the
hsp60 promoter (Fig. 3C). Rv0199 was not predicted to be
important in macrophages by TraSH analysis (40), although it
was predicted by another TraSH analysis to be important in a
mouse infection model (46). In contrast, Rv0199 was predicted
on the basis of pooled infections to be needed for M. bovis
BCG to grow in macrophages (50).
CtaC. Our ctaC::TnblaTEM-1 mutant had a growth defect in
macrophages (Fig. 4C). The ctaC gene encodes subunit II of
the cytochrome c oxidase, which is important for growth under
aerobic conditions (23). Along with TM and signal sequence
predictions (6, 49), the site of our active TnblaTEM-1 insertion
indicates that the C terminus of CtaC, which contains the
cytochrome oxidase domain, is on the extracytoplasmic face of
the membrane.
CtaC is predicted to be essential in M. tuberculosis H37Rv,
and an attempt to delete the gene in M. tuberculosis was un-
successful (33). However, we collected two identical
ctaC::TnblaTEM-1 mutants, and they did not have growth de-
fects in liquid (data not shown). This is likely due to the
BlaTEM-1 reporter truncating only the final 13 amino acids of
the C terminus. Colonies of the ctaC::TnblaTEM-1 mutant
were phenotypically rough and spread out in comparison to
parental MBTB126 colonies (Fig. 4D).
FIG. 3. M. tuberculosis rv0199::TnblaTEM-1 has a growth defect in
macrophages. (A) Organization of genes surrounding TnblaTEM-1 inser-
tion (triangle) in rv0199. (B) Membrane topology of Rv0199 predicted by
the TMHMM algorithm (49). The site of BlaTEM-1 fusion is indicated
with a triangle. (C) Macrophages were infected with MBTB126 carrying
the empty vector pMV261.kan, the rv0199::TnblaTEM-1 mutant carrying
pMV261.kan, or the rv0199::TnblaTEM-1 mutant carrying a multicopy
complementing vector expressing rv0199 from a constitutive promoter
(pJES178). Error bars indicate SD of the means. *, P  0.05. The graph
shows representative data from one of at least three independent replicate
experiments.
FIG. 4. M. tuberculosis ctaC::TnblaTEM-1 has a growth defect in
macrophages and a colony phenotype on agar plates. (A) Relative
location of ctaC in the M. tuberculosis genome. The black triangle
indicates the site of TnblaTEM-1 insertion. (B) Membrane topology
of CtaC predicted by the TMHMM algorithm (49). The site of
BlaTEM-1 fusion is indicated with a triangle. (C) Macrophage
infection as described in the legend for Fig. 3. Error bars indicate
SD of the means. *, P  0.05. The graph shows representative data
from one of at least three independent replicate experiments.
(D) M. tuberculosis MBTB126 and the ctaC::TnblaTEM-1 mutant
were plated on 7H10 agar plates supplemented with Tween 80.
Colonies were examined after 25 days at 37°C.
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Until complementation analysis is conducted, we can only
speculate on the basis of attenuated mutant phenotypes in
macrophages. For the ctaC::TnblaTEM-1 mutant, perhaps the
mutant has modestly compromised CtaC activity that is prob-
lematic to intracellular growth but not to in vitro growth. An-
other possibility is that the intracellular growth defect of the
ctaC::TnblaTEM-1 mutant is not caused by the insertion in ctaC
but is due to polar effects of the transposon (Fig. 4A). The ctaF
gene is directly downstream of ctaC. CtaF shares homology
with predicted cytochrome c subunit proteins in other myco-
bacteria and Rhodococcus (2). It is possible that CtaF works in
concert with CtaC in a multisubunit cytochrome c oxidase in
mycobacteria, or it may function in another capacity.
LppX. We identified active TnblaTEM-1 insertions in drrC
and lppX. These genes are near each other in the genome and
encode proteins required for translocation of the mycobacte-
rium-specific lipid phthiocerol dimycocerosate (PDIM) (10, 14,
55) to the bacterial surface (10, 14, 52) (Fig. 5A).
Our lppX::TnblaTEM-1 mutant was defective for growth in
macrophages (Fig. 5B). A macrophage phenotype was not,
however, observed with our drrC::TnblaTEM-1 mutant, even
though this mutant had an insertion truncating the protein at
amino acid 57 (Fig. 5A). To our knowledge, our results are the
first to report a macrophage phenotype for an lppX mutant.
While PDIM-deficient mutants are attenuated in virulence in a
mouse model of infection, a fadD26 mutant completely devoid
of PDIM was not reported to have a defect in resting macro-
phages (42). Furthermore, TraSH does not predict lppX to be
important for growth in macrophages (40).
Conclusions. In this work, we utilized a new reporter trans-
poson for large-scale identification of exported proteins of M.
tuberculosis. We established the subcellular locations of 111 M.
tuberculosis proteins and simultaneously collected a library of
mapped mutants, each with an insertion in an exported ORF,
for subsequent analyses. An important feature of our transpo-
son reporter strategy is that it operates as a selection, not a
screen. Screening for an exported fusion phenotype is required
with other reporters of protein export, such as PhoA (9), and
is a labor-intensive approach that limits the number of colonies
that can be surveyed. A positive-selection process made it
possible for us to collect in-frame reporter fusions to exported
proteins from 81,000 random transposon mutants. Given the
remarkable specificity and selection exhibited by our -lacta-
mase reporter transposon, similar reporters should be consid-
ered for comprehensive analyses of exported proteins in other
pathogens.
We found that 59% of the exported proteins we identified
have no defined or predicted function (see Table S1 in the
supplemental material), whereas only 27% of ORFs in the M.
tuberculosis genome are annotated as having an unknown func-
tion (http://tuberculist.epfl.ch/). This discrepancy emphasizes
how little we know about M. tuberculosis exported proteins.
The library of mapped transposon mutants reported here is a
valuable resource for assigning functions to these unknown
exported proteins and for identifying new proteins important
to pathogenesis. Furthermore, the mutant collection is of a size
where it is feasible to rigorously screen mutants individually for
phenotypes. For some of the mutants we identified as attenu-
ated in macrophages (ctaC, mce2F, and lppX mutants), this was
the first time that such a phenotype was observed. For other
mutants, our results provide necessary validation of predictions
from hybridization-based assessment of mutant pools or ad-
dress conflicting reports (for mce1A, mce1B, and rv0199) (21,
29, 40, 46, 47, 50). Importantly, complementation analysis of
the mce2F and rv0199 mutants provides a foundation for un-
raveling the functions of two new M. tuberculosis exported
proteins with roles in macrophage growth.
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